Our office has moved to the 5th floor of the Crosstown Building located at 801 Massachusetts Avenue. We are no longer located in the Shapiro Building.
Boston Medical Center’s Office Based Addiction Treatment (OBAT) Program was established in 2003 and currently serves over 800 patients, making it the largest hospital-based addiction treatment program in New England. The OBAT team treats patients with approved medications for substance use disorders including buprenorphine, injectable buprenorphine, injectable naltrexone, and oral naltrexone. Patients receive specialized treatment for their substance use disorder integrated within a primary care setting, allowing all their medical needs to be addressed by a team of providers. The OBAT Program has been recognized nationally and replicated within many outpatient settings, including primary care, family medicine, behavioral health, and OB/Gyn practices, among others.
Click here for resources and virtual supports during COVID-19 pandemic
Contact Us
5th Floor, Suite 5C
Crosstown Center 617.414.4107
Monday - Tuesday 8:00 AM - 7:30 PM; Wednesday 9:00 AM - 7:30PM; Thursday 8:00AM – 5:30PM; Friday 9:00 AM – 5:30 PM
Treatments & Services
The BMC OBAT Program provides the following services to patients:
- Family Medicine Center
- Addiction Psychiatry Treatment Program
- Center for Addiction Treatment for AdoLescent/Young adults who use SubsTances (CATALYST)
- Treatment for all types of substance use disorders, including opioid, alcohol, benzodiazepine, and stimulant use disorders
- Trained addiction experts including nurses, physicians, nurse practitioners, social workers, psychiatrists, patient care coordinators, medical assistants, and recovery coaches
- Medications for opioid use disorder (MOUD): buprenorphine (Suboxone), injectable buprenorphine (Sublocade), and naltrexone (Vivitrol, Revia)
- Same-day medication access
- Direct telephone access to the nursing team
- Compassionate and non-judgmental care
- Harm reduction services and resources
- Specialized services to justice-involved individuals, adolescents, pregnant and post-partum women, and those with brain injuries
- Assistance accessing social supports and other benefits (e.g., food, IDs, employment, insurance)
- Behavioral health and psychiatric services
- Access to short- and long-term birth control
- Screening and treatment options for HIV, hepatitis A, B, and C, and sexually transmitted infections (STI)
- Overdose education and access to naloxone (Narcan)
Our Team
Leadership Team
Colleen Labelle, MSN, RN-BC, CARN
Program Director
Emily Hurstak, MD, MPH, MAS
Medical Director
Lexie Bergeron, MPH, LCSW
Director of Operations
Provider Resources
Research Overview
Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness - Fine DR, Lewis E, Weinstock K, Wright J, Gaeta JM, Baggett TP. [published correction appears in JAMA Netw Open. 2021 Aug 2;4(8):e2128112]. JAMA Netw Open. 2021;4(3):e210477. Published 2021 Mar 1. doi:10.1001/jamanetworkopen.2021.0477
Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. - Weinstein ZM, Gryczynski G, Cheng DM, et al. Drug Alcohol Depend. 2018;189:166-171. doi:10.1016/j.drugalcdep.2018.05.010
Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse - Wason K, Potter A, Alves J, et al. . J Nurs Adm. 2021;51(9):424-429. doi:10.1097/NNA.0000000000001041
Residency and Fellowship Information
Addiction Medicine Fellowship
The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.
The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more
Latest from HealthCity
Boston Medical Center’s Addiction Conference Sparks Discussion on the Role of Nurses in SUD Treatment
A harm reduction nurse cites training and education as one way for more nurses to get on board with viewing addiction treatment holistically.
"We're All in This Together": BMC's Inaugural Addiction Conference Opens with Solidarity and Innovation Message
"None of the future innovations will happen without you by our side," said keynote speaker Dr. Bisola Ojikutu about addiction interventions.
BMC's Inaugural Addiction Conference Will Convene Experts and People With Lived Experience to Spark Change
Together for Hope, hosted by the Grayken Center for Addiction, will dive into themes of intersectionality, policy, harm reduction.
Uneven Access and High Costs: The State of Residential Addiction Treatment for Adolescents
A new study shows that 23 states don't have treatment facilities that accept Medicaid, limiting an at-risk population's access to treatment.
Addressing Social Determinants of Health Is Critical In Curbing Opioid Overdose Deaths, Study Finds
New research from BMC shows a 21% reduction in overdose deaths in communities that address social needs as a part of post-overdose outreach programs.
BMC Is Developing New Anti-Racism Addiction Treatment, Research, and Policy
After a research project engaging people with lived experience of SUD, BMC has findings on making addiction treatment better for Black patients.
What Is Harm Reduction?
An expert and advocate for harm reduction talks about how she meets patients where they are with treatment options, resources, and hope for tomorrow.
Finding Joy in Food: How Cooking With Others Can Bolster Recovery
BMC's Cooking for Recovery Program addresses nutrition, body image issues, and food access while providing space to make a home-cooked meal.
Helping Healthcare Providers Process Grief After Overdose Deaths
Losing patients to overdose can present special grief challenges for healthcare providers. Peer and employer support can help.
New Research Finds Strong Association Between Psychostimulant Prescriptions and Fatal Overdoses
These findings raise a need for reforming harm reduction education to include information about stimulant use.
How Can We Make Addiction Care More Appealing and Effective for Black Patients?
The team at BMC's Grayken Center for Addiction is undertaking a major project to answer this question by learning from Black community members.
BMC Psychiatrists Innovate to Treat Teenagers With Marijuana-Induced Psychosis
Cannabis has gotten more potent in the last 20 years, leading to new trends in children’s mental wellness.